Supplemental material
Emerging Microbes & Infections
Volume 12, 2023 - Issue 1
Open access
2,235
Views
2
CrossRef citations to date
0
Altmetric
Coronaviruses
SARS-CoV-2 infection-induced immunity reduces rates of reinfection and hospitalization caused by the Delta or Omicron variants
Marc-Antoine de La Vegaa Galveston National Laboratory, Department of Microbiology and Immunology, Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USAView further author information
, Efstathia Polychronopouloub Office of Biostatistics, University of Texas Medical Branch, Galveston, TX, USAView further author information
, Ara XIIIa Galveston National Laboratory, Department of Microbiology and Immunology, Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USAView further author information
, Zhe Dingc Viral Hemorrhagic Fevers Research Unit, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of China;d University of Chinese Academy of Sciences, Beijing, People’s Republic of ChinaView further author information
, Tong Chenc Viral Hemorrhagic Fevers Research Unit, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of China;d University of Chinese Academy of Sciences, Beijing, People’s Republic of ChinaView further author information
, Qixing Liuc Viral Hemorrhagic Fevers Research Unit, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of China;d University of Chinese Academy of Sciences, Beijing, People’s Republic of ChinaView further author information
, Jiaming Lanc Viral Hemorrhagic Fevers Research Unit, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
, Marie-Edith Nepveu-Traversye Global Urgent and Advanced Research and Development (GuardRX), Batiscan, CanadaView further author information
, Hugues Fausther-Bovendoe Global Urgent and Advanced Research and Development (GuardRX), Batiscan, CanadaView further author information
, Mohammed F. Zaidanf Department of Internal Medicine, Division of Pulmonary, Critical Care, & Sleep Medicine, University of Texas Medical Branch, Galveston, TX, USAView further author information
, Gary Wongc Viral Hemorrhagic Fevers Research Unit, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
, Gulshan Sharmag Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USAView further author information
& Gary P. Kobingera Galveston National Laboratory, Department of Microbiology and Immunology, Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USACorrespondence[email protected]
View further author information
show allView further author information
Article: e2169198
|
Received 21 Nov 2022, Accepted 11 Jan 2023, Published online: 01 Mar 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.